Abstract
Owing to their structure of small phosphate units, phosphate invert glasses have high crystallisation tendencies, which make processing of the melt challenging. The aim was to improve their processing by (1) increasing the number of glass components and (2) incorporating intermediate oxides (TiO2, MgO and ZnO). Glasses (P2O5–CaO–MgO–Na2O) were produced by a melt-quench route. In series 1, TiO2 was partially substituted for Na2O, and the number of components was increased by partially substituting strontium for calcium, zinc for magnesium and potassium for sodium on a molar base. In series 2, the MgO+ZnO content in the multicomponent glass was varied between 0 and 20mol% in exchange for CaO+SrO. Differential scanning calorimetry showed a significant increase of the processing window in the multicomponent glasses, explained by an increased energy barrier for crystallisation owing to increased entropy of mixing. The MgO+ZnO content also significantly improved the processing window from 117K (0mol% MgO+ZnO) to 185K (20mol%), owing to their large field strength. These results show that the processing of phosphate invert glasses for biomedical applications can be improved significantly by incorporating ions such as strontium or zinc which are also known to have therapeutic effects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
